HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytotoxic ester derivatives of the mammary tumor inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane.

Abstract
The synthesis of the bis-acrylate 12, the bis-beta-chloropropionate 13 and the bis-beta-bromopropionate 14 of the "partial" antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane (7) is described. In the case of 13 and 14 the introduction of the beta-haloester-functions moderately reduces the estrogen receptor affinity of 7. However, it was quite strongly diminished in 12. The hydrolytic stability under in vitro-receptor-assay conditions decreases in the order 12 greater than 14 greater than 13. Compared with 7 the estrogenic potency of 12-14 is increased to a great extent. The title compounds cause a strong inhibition of the hormone-dependent MXT-M3.2 mouse mammary tumor.
AuthorsW Schwarz, R W Hartmann, J Engel, M R Schneider, H Schönenberger
JournalArchiv der Pharmazie (Arch Pharm (Weinheim)) Vol. 323 Issue 2 Pg. 121-4 (Feb 1990) ISSN: 0365-6233 [Print] Germany
PMID2159273 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Estrogen Antagonists
  • Hexestrol
  • 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane
Topics
  • Animals
  • Antineoplastic Agents (chemical synthesis)
  • Cattle
  • Cell Survival (drug effects)
  • Chemical Phenomena
  • Chemistry
  • Chromatography, High Pressure Liquid
  • Estrogen Antagonists (chemical synthesis)
  • Hexestrol (analogs & derivatives, chemical synthesis, pharmacology)
  • In Vitro Techniques
  • Mammary Neoplasms, Experimental (drug therapy)
  • Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: